Published in Crit Care Med on December 01, 2007
Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms (SAVIOR) | NCT04368156
HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol (2011) 6.23
Harmful molecular mechanisms in sepsis. Nat Rev Immunol (2008) 6.03
Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science (2011) 5.87
Reflex control of immunity. Nat Rev Immunol (2009) 4.57
Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation. J Am Coll Cardiol (2015) 2.78
Cholinergic control of inflammation. J Intern Med (2009) 2.12
Targeting HMGB1 in inflammation. Biochim Biophys Acta (2009) 2.11
The pulse of inflammation: heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy. J Intern Med (2011) 2.08
Reflex principles of immunological homeostasis. Annu Rev Immunol (2012) 2.04
Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol Med (2008) 1.97
Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci U S A (2016) 1.74
Rethinking inflammation: neural circuits in the regulation of immunity. Immunol Rev (2012) 1.68
HMGB1 in health and disease. Mol Aspects Med (2014) 1.67
The neurology of the immune system: neural reflexes regulate immunity. Neuron (2009) 1.46
Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation. Brain Behav Immun (2014) 1.44
Therapeutic potential of HMGB1-targeting agents in sepsis. Expert Rev Mol Med (2008) 1.30
Novel HMGB1-inhibiting therapeutic agents for experimental sepsis. Shock (2009) 1.29
Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). Neuropsychopharmacology (2010) 1.25
Molecular events in the cardiomyopathy of sepsis. Mol Med (2008) 1.18
Damage-associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1. J Matern Fetal Neonatal Med (2011) 1.13
Neurostimulation of the cholinergic anti-inflammatory pathway ameliorates disease in rat collagen-induced arthritis. PLoS One (2014) 1.03
Immunomodulatory drugs regulate HMGB1 release from activated human monocytes. Mol Med (2010) 1.02
CNS leptin action modulates immune response and survival in sepsis. J Neurosci (2010) 1.01
Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Inflammation (2014) 1.00
α7 nicotinic acetylcholine receptor signaling inhibits inflammasome activation by preventing mitochondrial DNA release. Mol Med (2014) 0.97
Neural circuitry and immunity. Immunol Res (2015) 0.97
Anti-inflammatory role of fetuin-A in injury and infection. Curr Mol Med (2012) 0.96
Fetal cholinergic anti-inflammatory pathway and necrotizing enterocolitis: the brain-gut connection begins in utero. Front Integr Neurosci (2013) 0.94
High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation. Inflamm Allergy Drug Targets (2010) 0.92
Interplay between inflammation, immune system and neuronal pathways: effect on gastrointestinal motility. World J Gastroenterol (2010) 0.91
Effects of vagus nerve stimulation and vagotomy on systemic and pulmonary inflammation in a two-hit model in rats. PLoS One (2012) 0.91
The vagal immune reflex: a blessing from above. Wien Med Wochenschr (2010) 0.91
Vagus Nerve Stimulation. Curr Behav Neurosci Rep (2014) 0.90
Translational applications of evaluating physiologic variability in human endotoxemia. J Clin Monit Comput (2012) 0.90
Sepsis: links between pathogen sensing and organ damage. Curr Pharm Des (2008) 0.90
Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza. Evid Based Complement Alternat Med (2009) 0.90
Cholinergic modulation of inflammation. Int J Clin Exp Med (2008) 0.87
Heart rate variability predicts levels of inflammatory markers: Evidence for the vagal anti-inflammatory pathway. Brain Behav Immun (2014) 0.87
Controlling postoperative ileus by vagal activation. World J Gastroenterol (2010) 0.85
Modulation of inflammatory response via alpha2-adrenoceptor blockade in acute murine colitis. Clin Exp Immunol (2009) 0.84
Transcutaneous auricular vagus nerve stimulation protects endotoxemic rat from lipopolysaccharide-induced inflammation. Evid Based Complement Alternat Med (2012) 0.84
Sepsis and immune response. World J Emerg Med (2011) 0.83
Electrical vagus nerve stimulation and nicotine effects in peritonitis-induced acute lung injury in rats. Inflammation (2011) 0.83
Neuropeptide modulators of high mobility group box 1 secretion as potential therapeutic agents for severe sepsis. Am J Pathol (2008) 0.82
A new IRAK-M-mediated mechanism implicated in the anti-inflammatory effect of nicotine via α7 nicotinic receptors in human macrophages. PLoS One (2014) 0.80
Electric stimulation of the vagus nerve reduced mouse neuroinflammation induced by lipopolysaccharide. J Inflamm (Lond) (2016) 0.78
Disruption of a Regulatory Network Consisting of Neutrophils and Platelets Fosters Persisting Inflammation in Rheumatic Diseases. Front Immunol (2016) 0.77
Protective role of the cholinergic anti-inflammatory pathway in a mouse model of viral myocarditis. PLoS One (2014) 0.77
Stimulation of Brain AMP-Activated Protein Kinase Attenuates Inflammation and Acute Lung Injury in Sepsis. Mol Med (2015) 0.77
Effects of afferent and efferent denervation of vagal nerve on endotoxin-induced oxidative stress in rats. J Neural Transm (Vienna) (2013) 0.76
Vagal nerve stimulation in prevention and management of coronary heart disease. World J Cardiol (2011) 0.76
Transvenous vagus nerve stimulation does not modulate the innate immune response during experimental human endotoxemia: a randomized controlled study. Arthritis Res Ther (2015) 0.76
The Protective Effect of Alpha 7 Nicotinic Acetylcholine Receptor Activation on Critical Illness and Its Mechanism. Int J Biol Sci (2017) 0.75
Effects of a7nAChR agonist on the tissue estrogen receptor expression of castrated rats. Int J Clin Exp Pathol (2015) 0.75
Right Cervical Vagotomy Aggravates Viral Myocarditis in Mice Via the Cholinergic Anti-inflammatory Pathway. Front Pharmacol (2017) 0.75
Vagus nerve stimulation blocks vascular permeability following burn in both local and distal sites. Burns (2012) 0.75
Assessment of vagal activity during transcutaneous vagus nerve stimulation in mice. Crit Care Med (2008) 0.75
Non-neuronal cholinergic activity is potentiated in myasthenia gravis. BMC Neurol (2017) 0.75
Cholinergic Modulation of the Immune System Presents New Approaches for Treating Inflammation. Pharmacol Ther (2017) 0.75
Mechanical vagus nerve stimulation--A new adjunct in sepsis prophylaxis and treatment? Crit Care Med (2007) 2.78
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13.90
Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature (2002) 12.09
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol (2005) 11.57
Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A (2003) 7.14
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med (2005) 6.86
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med (2004) 6.38
HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol (2011) 6.23
Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science (2011) 5.87
Sepsis definitions: time for change. Lancet (2013) 5.63
MIF signal transduction initiated by binding to CD74. J Exp Med (2003) 4.79
Endogenous HMGB1 regulates autophagy. J Cell Biol (2010) 4.71
HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock (2006) 4.53
A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A (2010) 3.80
Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med (2003) 3.75
Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A (2002) 3.68
Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med (2006) 3.66
Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med (2007) 3.63
Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med (2005) 3.58
Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med (2007) 3.27
Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med (2006) 3.26
Novel role of PKR in inflammasome activation and HMGB1 release. Nature (2012) 3.13
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood (2007) 3.09
The cytokine activity of HMGB1. J Leukoc Biol (2005) 3.02
Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med (2005) 3.01
HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology (2002) 2.95
The "cytokine profile": a code for sepsis. Trends Mol Med (2005) 2.89
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med (2012) 2.89
Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol (2010) 2.88
Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med (2002) 2.83
Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med (2012) 2.79
Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell (2013) 2.69
Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci U S A (2008) 2.58
Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol (2003) 2.50
The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology (2006) 2.47
High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol (2006) 2.44
Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin. Mol Cell Biol (2004) 2.33
High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol (2004) 2.32
Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med (2003) 2.30